Literature DB >> 25628239

Strokes in Sneddon syndrome without antiphospholipid antibodies.

Laure Bottin1, Camille Francès, Dominique de Zuttere, Pierre-Yves Boëlle, Ioan-Paul Muresan, Sonia Alamowitch.   

Abstract

OBJECTIVE: Sneddon syndrome (SS) is characterized by the association of a livedo reticularis with stroke. Clinicoradiological features of its neurological manifestations, its prognosis, and the frequency of associated cardiac valvulopathy remain poorly known, particularly in the absence of antiphospholipid antibodies (APL). The objectives were to assess the clinicoradiological pattern of SS without APL (SSAPL- ) and its midterm prognosis.
METHODS: Clinical data, transthoracic echocardiograms, and brain imaging of 53 consecutive patients (83% women) with SSAPL- , followed up at our institution between 1991 and 2011, were reviewed.
RESULTS: Seventy-four strokes were reported; 76% were ischemic strokes (IS), 15% transient ischemic attacks, and 9% hemorrhagic strokes. Heart valve lesions were found in 50% of the cases. Brain imaging showed 177 IS of 3 different types: large territorial (43%), small distal corticosubcortical (14%), and small deep (23%) IS. No significant association was found between the valve involvement and the presence of territorial IS. After a mean follow-up of 7.4 years, 82% of patients had a modified Rankin Scale score ≤ 2. The ischemic event recurrence rate was 20%, with a similar annual rate in the antiplatelet group (3%) compared to the anticoagulation group (2.7%).
INTERPRETATION: SSAPL- is not only a neurocutaneous disorder, but is frequently associated with heart valve involvement. The latter does not influence the IS type, which suggests that strokes are caused by vasculopathy of the small and medium-size cerebral arteries. Our results show no progression toward a serious disability in the majority of the cases and a moderate recurrence rate under antiplatelet therapy.
© 2015 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25628239     DOI: 10.1002/ana.24382

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  Sneddon syndrome and non-bacterial thrombotic endocarditis: a clinicopathological study.

Authors:  José Berciano; Nuria Terán-Villagrá
Journal:  J Neurol       Date:  2018-07-06       Impact factor: 4.849

Review 2.  [Rare causes of stroke-a frequent stroke etiology].

Authors:  Antje Schmidt-Pogoda; Jens Minnerup
Journal:  Nervenarzt       Date:  2019-10       Impact factor: 1.214

Review 3.  Sneddon syndrome: under diagnosed disease, complex clinical manifestations and challenging diagnosis. A case-based review.

Authors:  Steve S Kong; Azin Azarfar; Neha Bhanusali
Journal:  Rheumatol Int       Date:  2020-06-12       Impact factor: 2.631

Review 4.  [Juvenile stroke - what is important?]

Authors:  M Fischer; B Eckert; J Röther
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

5.  Characteristic imaging features of neurovascular involvement in primary Sneddon's syndrome: an analysis of 12 cases.

Authors:  Ezgi Yilmaz; Ethem Murat Arsava; Rahşan Gocmen; Kader Karli Oguz; Anil Arat; Mehmet Akif Topcuoglu
Journal:  Neurol Sci       Date:  2020-10-13       Impact factor: 3.307

6.  Long-term follow-up of early-onset Sneddon syndrome: A case report.

Authors:  Stephan Forchhammer; Gisela Metzler; Kamran Ghoreschi
Journal:  JAAD Case Rep       Date:  2018-10-03

7.  A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke.

Authors:  Elli Katharine Greisenegger; Sara Llufriu; Angel Chamorro; Alvaro Cervera; Adriano Jimenez-Escrig; Klemens Rappersberger; Wolfgang Marik; Stefan Greisenegger; Elisabeth Stögmann; Tamara Kopp; Tim M Strom; Jörg Henes; Anne Joutel; Alexander Zimprich
Journal:  J Neurol       Date:  2020-09-26       Impact factor: 4.849

Review 8.  Neuropsychiatric Manifestations of Antiphospholipid Syndrome-A Narrative Review.

Authors:  Yik Long Man; Giovanni Sanna
Journal:  Brain Sci       Date:  2022-01-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.